首页> 美国卫生研究院文献>Integrative Cancer Therapies >Heart Rate Variability as a Marker of Distress and Recovery: TheEffect of Brief Supportive Expressive Group Therapy With Mindfulness in CancerPatients
【2h】

Heart Rate Variability as a Marker of Distress and Recovery: TheEffect of Brief Supportive Expressive Group Therapy With Mindfulness in CancerPatients

机译:心率变异性是困扰和恢复的标志:正念短暂支持性团体治疗对癌症的影响耐心

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives. We aimed to investigate the effects of brief supportive expressive group therapy with mindfulness for cancer patients and to assess the utility of heart rate variability (HRV) as a biomarker of distress and treatment effect. Methods. A total of 28 female patients with nonmetastatic cancer at a university hospital in South Korea received a 4-week modified group therapy for distress reduction. The BESTMIND (Brief Expression and Support Therapy with Mindfulness) program consisted of supportive–expressive group therapy and mindfulness-based stress reduction. The subjective outcomes of distress, anger, sleep quality, and sense of well-being and the physiological outcome of HRV were assessed before and after the program. Results. After the program, patients showed significantly reduced distress, perceived stress, anger, and sleep disturbance and increased quality of life. No significant change was observed in the degree of mindfulness. A significantly increased SD in the normal beat-to-beat intervals and normalized high-frequency (HF 0.15-0.4 Hz) power from spectral analysis were observed after treatment. According to the correlation analyses, HF power correlated with depression scores, and normalized HF power was associated withdepression, anxiety, perceived stress, and anger at baseline. The pretreatmentand posttreatment comparison indicated that an increase in HF power wasassociated with a decrease in anger. Conclusions. These resultssuggest the effectiveness of this modified group-based program for distressreduction and also provide preliminary evidence for the use of HRV as abiomarker of distress and recovery. HF power from HRV variables may serve as aquantitative biomarker of the treatment response of distress management,including anger.
机译:目标。我们旨在研究短暂的支持性表达集体疗法对癌症患者的正念治疗效果,并评估心率变异性(HRV)作为困扰和治疗效果的生物标志物的效用。方法。韩国一所大学医院的总共28名患有非转移性癌症的女性患者接受了为期4周的改良组疗法以减轻痛苦。 BESTMIND(带有正念的简短表达和支持疗法)程序包括支持性-表达性集体疗法和基于正念的压力减轻。在计划之前和之后,评估主观痛苦,愤怒,睡眠质量和幸福感以及HRV的生理结果。结果。实施该程序后,患者的痛苦,感知压力,愤怒和睡眠障碍明显减少,生活质量得到改善。在正念度上没有观察到显着变化。治疗后观察到正常拍频间隔中SD显着增加,频谱分析显示归一​​化高频(HF 0.15-0.4 Hz)功率。根据相关分析,HF功率与抑郁评分相关,归一化的HF功率与抑郁评分相关。基线时有抑郁,焦虑,感觉到的压力和愤怒。预处理和后处理的比较表明HF功率增加了与减少愤怒有关。结论。这些结果建议修改后的基于小组的遇险方案的有效性减少使用率,并为将HRV用作痛苦和恢复的生物标志物。来自HRV变量的HF功率可以用作遇险管理的治疗反应的定量生物标志物,包括愤怒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号